BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 14578481)

  • 41. Localization and characterization of pituitary adenylate cyclase-activating polypeptide receptors in the human cerebellum during development.
    Basille M; Cartier D; Vaudry D; Lihrmann I; Fournier A; Freger P; Gallo-Payet N; Vaudry H; Gonzalez B
    J Comp Neurol; 2006 Jun; 496(4):468-78. PubMed ID: 16572459
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential regulation of activity-dependent neuroprotective protein in rat astrocytes by VIP and PACAP.
    Zusev M; Gozes I
    Regul Pept; 2004 Dec; 123(1-3):33-41. PubMed ID: 15518891
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PACAP and PAC1 receptor in brain development and behavior.
    Shen S; Gehlert DR; Collier DA
    Neuropeptides; 2013 Dec; 47(6):421-30. PubMed ID: 24220567
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Generation of highly selective VPAC2 receptor agonists by high throughput mutagenesis of vasoactive intestinal peptide and pituitary adenylate cyclase-activating peptide.
    Yung SL; Dela Cruz F; Hamren S; Zhu J; Tsutsumi M; Bloom JW; Caudle M; Roczniak S; Todd T; Lemoine L; MacDougall M; Shanafelt AB; Pan CQ
    J Biol Chem; 2003 Mar; 278(12):10273-81. PubMed ID: 12525492
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PACAP deficient mice display reduced carbohydrate intake and PACAP activates NPY-containing neurons in the rat hypothalamic arcuate nucleus.
    Nakata M; Kohno D; Shintani N; Nemoto Y; Hashimoto H; Baba A; Yada T
    Neurosci Lett; 2004 Nov; 370(2-3):252-6. PubMed ID: 15488333
    [TBL] [Abstract][Full Text] [Related]  

  • 46. VIP/PACAP receptor mediation of cutaneous active vasodilation during heat stress in humans.
    Kellogg DL; Zhao JL; Wu Y; Johnson JM
    J Appl Physiol (1985); 2010 Jul; 109(1):95-100. PubMed ID: 20395540
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of key residues that cause differential gallbladder response to PACAP and VIP in the guinea pig.
    Wei M; Fujiki K; Ando E; Zhang S; Ozaki T; Ishiguro H; Kondo T; Nokihara K; Wray V; Naruse S
    Am J Physiol Gastrointest Liver Physiol; 2007 Jan; 292(1):G76-83. PubMed ID: 16901992
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vasoactive intestinal polypeptide VPAC1 and VPAC2 receptor chimeras identify domains responsible for the specificity of ligand binding and activation.
    Juarranz MG; Van Rampelbergh J; Gourlet P; De Neef P; Cnudde J; Robberecht P; Waelbroeck M
    Eur J Biochem; 1999 Oct; 265(1):449-56. PubMed ID: 10491203
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modulation of AMPA receptor-mediated ion current by pituitary adenylate cyclase-activating polypeptide (PACAP) in CA1 pyramidal neurons from rat hippocampus.
    Costa L; Santangelo F; Li Volsi G; Ciranna L
    Hippocampus; 2009 Jan; 19(1):99-109. PubMed ID: 18727050
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mechanisms of VIP-induced neuroprotection against neonatal excitotoxicity.
    Rangon CM; Dicou E; Goursaud S; Mounien L; Jégou S; Janet T; Muller JM; Lelièvre V; Gressens P
    Ann N Y Acad Sci; 2006 Jul; 1070():512-7. PubMed ID: 16888217
    [TBL] [Abstract][Full Text] [Related]  

  • 51. VIP attenuation of the severity of experimental pancreatitis is due to VPAC1 receptor-mediated inhibition of cytokine production.
    Kojima M; Ito T; Oono T; Hisano T; Igarashi H; Arita Y; Kawabe K; Coy DH; Jensen RT; Nawata H
    Pancreas; 2005 Jan; 30(1):62-70. PubMed ID: 15632701
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles.
    Vaccari S; Latini S; Barberi M; Teti A; Stefanini M; Canipari R
    J Endocrinol; 2006 Oct; 191(1):287-99. PubMed ID: 17065411
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A structure-function study of PACAP using conformationally restricted analogs: Identification of PAC1 receptor-selective PACAP agonists.
    Ramos-Álvarez I; Mantey SA; Nakamura T; Nuche-Berenguer B; Moreno P; Moody TW; Maderdrut JL; Coy DH; Jensen RT
    Peptides; 2015 Apr; 66():26-42. PubMed ID: 25698233
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Heterogeneity of neuronal and smooth muscle receptors involved in the VIP- and PACAP-induced relaxations of the pig intravesical ureter.
    Hernández M; Barahona MV; Recio P; Rivera L; Benedito S; Martínez AC; García-Sacristán A; Orensanz LM; Prieto D
    Br J Pharmacol; 2004 Jan; 141(1):123-31. PubMed ID: 14662737
    [TBL] [Abstract][Full Text] [Related]  

  • 55. VPAC2 receptors mediate vasoactive intestinal peptide-induced neuroprotection against neonatal excitotoxic brain lesions in mice.
    Rangon CM; Goursaud S; Medja F; Lelièvre V; Mounien L; Husson I; Brabet P; Jégou S; Janet T; Gressens P
    J Pharmacol Exp Ther; 2005 Aug; 314(2):745-52. PubMed ID: 15872042
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of novel splice variants of the PAC1 receptor in human neuroblastoma cells: consequences for signaling by VIP and PACAP.
    Lutz EM; Ronaldson E; Shaw P; Johnson MS; Holland PJ; Mitchell R
    Mol Cell Neurosci; 2006 Feb; 31(2):193-209. PubMed ID: 16226889
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Calmodulin interacts with PAC1 and VPAC2 receptors and regulates PACAP-induced FOS expression in human neuroblastoma cells.
    Falktoft B; Georg B; Fahrenkrug J
    Neuropeptides; 2009 Apr; 43(2):53-61. PubMed ID: 19269029
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of vasoactive intestinal peptide and related receptors in overcirculation-induced pulmonary hypertension in piglets.
    Vuckovic A; Rondelet B; Brion JP; Naeije R
    Pediatr Res; 2009 Oct; 66(4):395-9. PubMed ID: 19581838
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pituitary adenylate cyclase-activating polypeptide (PACAP) potently dilates middle meningeal arteries: implications for migraine.
    Syed AU; Koide M; Braas KM; May V; Wellman GC
    J Mol Neurosci; 2012 Nov; 48(3):574-83. PubMed ID: 22766684
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacological characterization of VIP and PACAP receptors in the human meningeal and coronary artery.
    Chan KY; Baun M; de Vries R; van den Bogaerdt AJ; Dirven CM; Danser AH; Jansen-Olesen I; Olesen J; Villalón CM; MaassenVanDenBrink A; Gupta S
    Cephalalgia; 2011 Jan; 31(2):181-9. PubMed ID: 20974589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.